Bariatric Surgery Following Treatment for Craniopharyngioma: A Systematic Review and Individual-Level Data Meta-Analysis
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Craniopharyngiomas are rare low-grade tumors located in the hypothalamic and/or pituitary region. Hypothalamic involvement and treatment resulting in hypothalamic damage are known to lead to development of "hypothalamic obesity" (HyOb) in 50% of cases. The management of HyOb, associated with eating disorders and rapid comorbidities, is an important issue. Bariatric surgery is the most effective therapy for weight loss in patients with severe exogenous obesity. The aim of this systematic review and meta-analysis was to determine the 12-month outcome of bariatric surgery for HyOb due to craniopharyngioma treatment. METHODS AND RESULTS: Relevant studies were identified by searches of the MEDLINE and EMBASE databases until January 2013. A total of 21 cases were included: 6 with adjustable gastric banding, 8 with sleeve gastrectomy, 6 with Roux-en-Y gastric bypass, and 1 with biliopancreatic diversion. After data pooling, mean weight difference was -20.9 kg after 6 months (95% confidence interval [CI], -35.4, -6.3) and -15.1 kg after 12 months (95% CI, -31.7, +1.4). The maximal mean weight loss was achieved by the gastric bypass group: -31.0 kg (95% CI, -77.5, +15.5) and -33.7 kg (95% CI, -80.7, +13.3) after 6 and 12 months, respectively. CONCLUSIONS: In this largest ever published study on the effect of bariatric surgery on obesity after craniopharyngioma treatment, we observed an important weight loss after 1 year of follow-up. Larger studies are warranted to establish appropriate selection criteria and the best surgical technique to perform bariatric surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared to results in normal controls, total weight reduction during 2 years was lower for other interventions but RYGB (153).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [153]
In the citing paper
“In 2013, Bretault et al (153) reviewed in their individual-level meta-analysis a total of 21 cases of CP and found significant weight loss at 6 months and 12 months after bariatric surgery (−0.9%TWL/6 months, −15.1%TWL/12 months). The greatest weight reduction was achieved after Roux-en-Y gastric bypass (RYGB).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [153]
In the citing paper
“Bariatric interventions demonstrated notable effectiveness in weight loss and safety in patients with CP (152-154).”
From Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; It Is More Than Obesity (2025) · cites this paper as [153]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Gastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163
Mechanick, J. I., Youdim, A., Jones, D. B., Garvey, W. T., Hurley, D. L., McMahon, M. M., Heinberg, L. J., Kushner, R., Adams, T. D., Shikora, S., et al. (2013) · Obesity · doi:10.1002/oby.20461 · Cited by 1,650
Abizaid, A., Liu, Z.-W., Andrews, Z. B., Shanabrough, M., Borok, E., Elsworth, J. D., Roth, R. H., Sleeman, M. W., Picciotto, M. R., Tschöp, M. H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29867 · Cited by 984 · cited 1×
“In this regard, it is known that receptors for ghrelin, an orexigenic gut hormone that is believed important for appetite, are found in various regions, including the brainstem and midbrain (34, 35), which would not predictably be damaged by treatment of a tumor located in the sellar or parasellar region.”
Laferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682
Müller, H. L., Emser, A., Faldum, A., Bruhnken, G., Etavard-Gorris, N., Gebhardt, U., Oeverink, R., Kolb, R., & Sörensen, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031751 · Cited by 287
Self-citationHamilton, J., Conwell, L., Syme, C., Ahmet, A., Jeffery, A., & Daneman, D. (2011) · International Journal of Pediatric Endocrinology · doi:10.1155/2011/417949 · Cited by 109 · cited 1×
“Several medical treatment options have been explored in patients with “hypothalamic obesity” (HyOb), such as the use of adrenergics to enhance and mimic sympathetic activity (9–12), or lowering of insulin secretion with hypoglycemic agents such as octreotide or diazoxide (13, 14).”
Research works printed but not linked: 48
- Bunin, 1998, The descriptive epidemiology of craniopharyngioma, J Neurosurg, 89, 547, 10.3171/jns.1998.89.4.0547 · DOI · Paper page
- Hermann, 2011, Consequences of craniopharyngioma surgery in children, J Clin Endocrinol Metab, 96, 1981, 10.1210/jc.2011-0174 · DOI · Paper page
- Müller, 2001, Obesity after craniopharyngioma: German multicenter study on pre-operative risk factors and quality of life, Klin Padiatr, 213, 244, 10.1055/s-2001-16855 · DOI · Paper page
- Ahmet, 2006, Weight gain in craniopharyngioma: a model for hypothalamic obesity, J Pediatr Endocrinol Metab, 19, 121, 10.1515/JPEM.2006.19.2.121 · DOI · Paper page
- Lustig, 2003, Risk factors for the development of obesity in children surviving brain tumors, J Clin Endocrinol Metab, 88, 611, 10.1210/jc.2002-021180 · DOI · Paper page
- Gautier, 2012, Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients, J Clin Endocrinol Metab, 97, 2011, 10.1210/jc.2011-2817 · DOI · Paper page
- Lustig, 2011, Hypothalamic obesity after Craniopharyngioma: mechanisms, diagnosis, and treatment, Front Endocrinol (Lausanne), 2, 60, 10.3389/fendo.2011.00060 · DOI · Paper page
- Danielsson, 2007, Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes, J Clin Endocrinol Metab, 92, 4101, 10.1210/jc.2007-0826 · DOI · Paper page
- Mason, 2002, The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma, Arch Pediatr Adolesc Med, 156, 887, 10.1001/archpedi.156.9.887 · DOI · Paper page
- Page-Wilson, 2012, Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery, Pituitary, 15, 84, 10.1007/s11102-011-0349-5 · DOI
- Lustig, 1999, Hypothalamic obesity in children caused by cranial insult: altered glucose and insulin dynamics, and reversal by a somatostatin agonist, J Pediatr, 135, 162, 10.1016/S0022-3476(99)70017-X · DOI · Paper page
- Lemmens, 2008, A systematic review of the evidence regarding efficacy of obesity prevention interventions among adults, Obes Rev, 9, 446, 10.1111/j.1467-789X.2008.00468.x · DOI · Paper page
- Lara, 2011, What kind of intervention has the best results to reduce the weight in overweighted or obese adults?, Arch Latinoam Nutr, 61, 45
- Colquitt, 2009, Surgery for obesity, Cochrane Database Syst Rev, CD003641
- Padwal, 2011, Bariatric surgery: a systematic review and network meta-analysis of randomized trials, Obes Rev, 12, 602, 10.1111/j.1467-789X.2011.00866.x · DOI · Paper page
- Bingham, 2012, Bariatric surgery in hypothalamic obesity, Front Endocrinol (Lausanne), 3, 23, 10.3389/fendo.2012.00023 · DOI
- Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
- Hedges, 1985, Statistical methods for meta-analysis
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Weismann, 2013, Bariatric surgery for morbid obesity in craniopharyngioma, Clin Endocrinol (Oxf), 78, 385, 10.1111/j.1365-2265.2012.04409.x · DOI · Paper page
- Rottembourg, 2009, Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma, J Pediatr Endocrinol Metab, 22, 867, 10.1515/JPEM.2009.22.9.867 · DOI · Paper page
- Müller, 2007, First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity, Klin Pädiatr, 219, 323, 10.1055/s-2007-985848 · DOI · Paper page
- Inge, 2007, Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy, Nat Clin Pract Endocrinol Metab, 3, 606, 10.1038/ncpendmet0579 · DOI
- Gatta, 2013, Is bariatric surgery really inefficient in hypothalamic obesity?, Clin Endocrinol (Oxf), 78, 636, 10.1111/cen.12031 · DOI
- Bender, 2011, Beneficial results of sleeve gastrectomy in a 12-year old girl with massive hyperphagia after surgery for craniopharyngioma, Obes Surg, 21, 956
- Schultes, 2009, Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma, Eur J Endocrinol, 161, 201, 10.1530/EJE-09-0079 · DOI
- Sarson, 1981, Gut hormone changes after jejunoileal or biliopancreatic bypass surgery for morbid obesity, Int J Obes, 5, 471
- Vinchon, 2009, Craniopharyngioma and hypothalamic obesity in children, Childs Nerv Syst, 25, 347, 10.1007/s00381-008-0754-x · DOI
- Hou, 2006, Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat, Regul Pept, 134, 126, 10.1016/j.regpep.2006.02.005 · DOI
- De Silva, 2012, The use of functional MRI to study appetite control in the CNS, Exp Diabetes Res, 2012, 764017, 10.1155/2012/764017 · DOI · Paper page
- De Silva, 2011, The gut hormones PYY3-36 and GLP-17-36 amide reduce food intake and modulate brain activity in appetite centers in humans, Cell Metab, 14, 700, 10.1016/j.cmet.2011.09.010 · DOI · Paper page
- Kral, 1978, Vagotomy for treatment of severe obesity, Lancet, 1, 307, 10.1016/S0140-6736(78)90074-0 · DOI
- Angrisani, 2009, Laparoscopic adjustable gastric banding with truncal vagotomy versus laparoscopic adjustable gastric banding alone: results of a prospective randomized trial, Surg Obes Relat Dis, 5, 435, 10.1016/j.soard.2008.08.024 · DOI
- Wiegele, 2010, Impressive weight reduction following laparoscopic gastric bypass surgery in a 16-year old girl with suprasellar craniopharyngioma and extreme hypothalamic obesity, Neuro Oncol, 12, II122
- Boza, 2012, Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up, Obes Surg, 22, 866, 10.1007/s11695-012-0591-6 · DOI
- Holterman, 2012, Patterns of surgical weight loss and resolution of metabolic abnormalities in superobese bariatric adolescents, J Pediatr Surg, 47, 1633, 10.1016/j.jpedsurg.2012.02.002 · DOI
- Nadler, 2007, Short-term results in 53 obese pediatric patients treated with laparoscopic adjustable gastric banding, J Pediatr Sur, 42, 137, 10.1016/j.jpedsurg.2006.09.014 · DOI
- Nadler, 2012, Early results after laparoscopic sleeve gastrectomy in adolescents with morbid obesity, Surgery, 152, 212, 10.1016/j.surg.2012.05.010 · DOI
- O'Brien, 2010, Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial, JAMA, 303, 519, 10.1001/jama.2010.81 · DOI · Paper page
- Pallati, 2012, Trends in adolescent bariatric surgery evaluated by UHC database collection, Surg Endosc, 26, 3077, 10.1007/s00464-012-2318-0 · DOI
- Ibele, 2011, Adolescent bariatric surgery, Surg Clin North Am, 91, 1339, 10.1016/j.suc.2011.08.005 · DOI
- Hsia, 2012, Adolescent bariatric surgery, Arch Pediatr Adolesc Med, 166, 757, 10.1001/archpediatrics.2012.1011 · DOI
- August, 2008, Prevention and treatment of pediatric obesity: an Endocrine Society Clinical Practice Guideline based on expert opinion, J Clin Endocrinol Metab, 93, 4576, 10.1210/jc.2007-2458 · DOI · Paper page
- IPEG Standard and Safety Committee, 2009, IPEG guidelines for surgical treatment of extremely obese adolescents, J Laparoendosc Adv Surg Tech A, 19, xiv, 10.1089/lap.2009.9981.supp · doi:10.1089/lap.2009.9981.supp
- Inge, 2010, Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass, J Pediatr, 156, 103, 10.1016/j.jpeds.2009.07.028 · DOI · Paper page
- Padwal, 2010, A systematic review of drug absorption following bariatric surgery and its theoretical implications, Obes Rev, 11, 41, 10.1111/j.1467-789X.2009.00614.x · DOI · Paper page
- Day, 2010, Evidence-based medicine and rare diseases, Adv Exp Med Biol, 686, 41, 10.1007/978-90-481-9485-8_3 · DOI
- Carey, 2010, The importance of case reports in advancing scientific knowledge of rare diseases, Adv Exp Med Biol, 686, 77, 10.1007/978-90-481-9485-8_5 · doi:10.1007/978-90-481-9485-8_5
Cited by
ASMBS pediatric metabolic and bariatric surgery guidelines, 2018
Pratt, J. S. A., Browne, A., Browne, N. T., Bruzoni, M., Cohen, M., Desai, A., Inge, T., Linden, B. C., Mattar, S. G., Michalsky, M., et al. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.03.019 · Cited by 555
Self-citationMüller, H. L., Merchant, T. E., Warmuth-Metz, M., Martinez-Barbera, J.-P., & Puget, S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0125-9 · Cited by 515
Self-citationMüller, H. L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1115 · Cited by 401
Self-citationvan Iersel, L., Brokke, K. E., Adan, R. A. H., Bulthuis, L. C. M., van den Akker, E. L. T., & van Santen, H. M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00017 · Cited by 146
Müller, H. L., Tauber, M., Lawson, E. A., Özyurt, J., Bison, B., Martinez-Barbera, J.-P., Puget, S., Merchant, T. E., & van Santen, H. M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00351-z · Cited by 144
Metadata
- Authors
- Bretault, M., Boillot, A., Muzard, L., Poitou, C., Oppert, J.-M., Barsamian, C., Gatta, B., Müller, H., Weismann, D., Rottembourg, D., Inge, T., Veyrie, N., Carette, C., & Czernichow, S.
- Affiliations
- Department of Nutrition (M.B., L.M., C.B., C.C., S.C.), Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), 75014 Paris, France
- Department of Periodontology (A.B.), Rothschild Hospital (AP-HP), 75571 Paris, France; University Paris 7, 75012 Paris, France
- University of Versailles St Quentin en Yvelines (L.M., S.C.), 92100 Boulogne Billancourt, France
- Department of Nutrition (C.P., J.-M.O.), Pitié-Salpêtrière Hospital (AP-HP), 75013 Paris, France
- Department of Endocrinology, Diabetology, and Metabolic Diseases (B.G.), Haut Leveque Hospital, Pessac, University of Bordeaux Segalen, 33076 Bordeaux, France
- Department of Pediatrics, Hematology, and Oncology (H.M.), Zentrum für Kinder-und Jugendmedizin, Klinkum Oldenburg gGmbH, 26133 Oldenburg, Germany
- Department of Internal Medicine I (D.W.), Endocrine and Diabetes Unit, University of Wuerzburg, 97080 Wuerzburg, Germany
- Department of Pediatrics (D.R.), Division of Endocrinology, Sherbrooke University Hospital, University of Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4
- Department of Surgery (T.I.), Division of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital, Cincinnati, Ohio 45229
- Department of Digestive and Metabolic Surgery (N.V.), Ambroise Paré Hospital (AP-HP), 75014 Paris, France
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-06-01
- Volume
- 98
- Issue
- 6
- Pages
- 2239-2246
- ISSN
- 0021-972X
- 1945-7197
- Cited by
- 98
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.